Cargando…
When myasthenia gravis is deemed refractory: clinical signposts and treatment strategies
The prognosis for patients with myasthenia gravis (MG) has improved significantly over the past half century, including substantial reductions in mortality and morbidity. However, approximately 10% of patients fails to respond adequately to current therapies and are considered treatment refractory,...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
SAGE Publications
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5791553/ https://www.ncbi.nlm.nih.gov/pubmed/29403543 http://dx.doi.org/10.1177/1756285617749134 |